Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma Academic Article uri icon

Overview

MeSH Major

  • Central Nervous System Neoplasms
  • Indium Radioisotopes
  • Radioimmunotherapy
  • Yttrium Radioisotopes

abstract

  • The results from this study suggest that it may be feasible to deliver radiolabeled monoclonal anti-CD20 antibodies as a component of therapy for PCNSL.

publication date

  • December 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.23077

PubMed ID

  • 17932895

Additional Document Info

start page

  • 2528

end page

  • 34

volume

  • 110

number

  • 11